Acquiring Company
GSK
Acquired Company
Affinivax
Description
GSK is set to acquire US biotechnology company Affinivax for $10.6 billion. The acquisition is part of GSK's strategy to expand its operations in therapeutics and biotechnology. To fund this acquisition, GSK plans to issue approximately $6 billion in bonds. This move aims to restructure financial obligations and enhance cash flow management.
Don't miss GSK's next move
Get an email the moment GSK makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired Affinivax?
Affinivax was acquired by GSK, based in London. The deal was reported on September 9, 2026. GSK is a global healthcare company engaged in the research, development, and manufacture of pharmaceutical products and vaccines. It focuses on providing innovative healthcare solutions and improving patient outcomes. GSK is publicly traded (GSK) and operates in Manufacturing.
When did GSK acquire Affinivax?
GSK's acquisition of Affinivax was reported on September 9, 2026. GSK is set to acquire US biotechnology company Affinivax for $10.6 billion. The acquisition is part of GSK's strategy to expand its operations in therapeutics and biotechnology. To fund this acquisition, GSK plans to issue approximately $6 billion in bonds. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Affinivax do?
Affinivax is a biotechnology company focused on developing innovative vaccines. The company leverages advanced scientific techniques to address significant public health challenges. Affinivax's mission is to improve vaccine efficacy through novel approaches. It is privately held, operating in Biotechnology, and is based in United States.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.